3190 results for «622»

Filter By

3190 results

How to treat coronary aneurysm

18 May 2023 – From EuroPCR 2023

Treating coronary aneurysms requires careful consideration and depends on several facors such as specifics characteristics of the aneurysms and patient’s conditions. Learn more the way to treat them throught this series of cases: massive thrombosis of an RCA aneurysm ; new insight toward understanding WOVEN like...

How to treat coronary aneurysm

Intracoronary imaging in left main - Part 1

18 May 2023 – From EuroPCR 2023

Explore the world of intracoronary imaging in left main interventions in this session: discover a fascinating case report on overcoming left main stent pop-up, delve into the application of OCT-guided nano crush technique for left main bifurcation lesions, uncover the management of stent failure involving the...

Intracoronary imaging in left main - Part 1

Knocking mitral regurgitation down to improve outcomes: earlier is better, but better late than never! (Episode 2: the left side)

18 May 2023 – From EuroPCR 2023

Help optimize your patients' prognosis by attending this session! You'll learn how proper patient selection and timely interventions lead to lasting results and how to use the latest real-world registry data to gain insight into the safety and effectiveness of M TEER.

Knocking mitral regurgitation

Management of PCI complications

16 May 2023 – From EuroPCR 2023

Listen to speakers explore the landscape of PCI complications, dissecting their impact, strategies for skillful management and ways to optimize patient outcomes. Advance your own understanding of this important problem and discover a range of approaches to mitigating it.

Management of PCI complications

Shock with valve disease - Part 1

17 May 2023 – From EuroPCR 2023

Discover here some compelling clinical cases on shock and valve disease. Experience real-life scenarios that will help you gain valuable knowledge and improve your clinical decision-making skills.

Shock and valve disease

Aortic complications

17 May 2023 – From EuroPCR 2023

Enhance your understanding of managing aortic complications effectively by exploring a comprehensive series of clinical cases presented at EuroPCR. Cases studied include in particular – How to manage iatrogenic aortic dissection during TAVI- Pseudoaneurysm after TAVI, how to close the hole- Aortic dissection following TAVI and...

Aortic complications

Transcatheter tricuspid valve replacement - LIVE case

15 May 2024 – From EuroPCR 2024

An 82-year-old male with a history of STEMI in 2013, stroke in 2018, cancer, and permanent AF, presented with acute heart failure with predominant right-side failure. Severe tricuspid regurgitation was identified.
The operators implanted an Evoque valve percutaneously under TEE guidance and general anaesthesia via the venous...

Transcatheter tricuspid valve replacement

Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial

29 Mar 2025

Aaysha Cader provides her take on the ECLIPSE trial presented by Gregg W. Stone at ACC.25 in Chicago.

Author

Aaysha Cader
Impact of intravascular imaging guidance on percutaneous coronary intervention of severely calcified lesions: The ECLIPSE trial

The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis

22 Mar 2022

Daniele Giacoppo analyses the main results of the FLAVOUR trial which were presented by Bon-Kwon Koo, from Seoul National University Hospital, South Korea at the American College of Cardiology 2022. 

Daniele Giacoppo

Author

Daniele Giacoppo
The FLAVOUR Randomized Clinical Trial: Comparison of Fractional Flow Reserve-guided and Intravascular Ultrasound-guided Percutaneous Coronary Intervention in Intermediate Coronary Artery Stenosis

Long-term beta-blocker treatment after acute myocardial infarction and preserved left ventricular ejection fraction: The REDUCE-AMI Trial

07 Apr 2024

REDUCE-AMI is a multicentre, registry-based, prospective open-label parallel-group randomised clinical trial evaluating the benefit of beta-blocker treatment in patients with acute MI and an ejection fraction >50% treated with a contemporary reperfusion strategy.

Nicola Ryan and Ali Nazmi Calik provide their take on the results which were presented...

Nicola Ryan

Author

Nicola Ryan

Author

Ali Nazmi Calik
REDUCE-AMI: Long-term beta-blocker treatment after AMI and preserved LVEF
Didn’t find what you were looking for?